Dr. Tara Chand Gupta

M.D. D.M. Medical Oncology

Specialist in Chemotherapy, Targeted Therapy and Immunotherapy

Dr. Tara Chand Gupta, a medical oncologist, is having more than 8 years of experience in Oncology. He was amongst the top 5 candidates in all India Level Entrance tests of Tata Memorial Hospital, Mumbai. He started his medical journey from the prestigious S.M.S Medical College, Jaipur in 2001 by reaching the top 30th position in Rajasthan Pre-Medical Examination. After M.B.B.S, he pursued M.D in General Medicine from the S.N Medical College, Agra ...While pursuing M.D, his interests got inclined towards treating cancer. And thereafter, he pursued D.M in Medical Oncology from the renowned Tata Memorial Hospital, Mumbai. He was also an Ex-Specialist Senior Registrar in Medical Oncology Department there. He was an Ex-Senior resident in the medical oncology department at Safdarjung hospital, New Delhi Dr. Tara Chand Gupta has given many theses and published research papers in the field of oncology. His expertise includes blood cancer treatment, Breast Cancer Treatment, Lung Cancer, Intestine Cancer, and Prostate Cancer. Currently, Dr. Gupta is serving as Consultant in Medical Oncology at Bhagwan Mahaveer Hospital & Research Center, Jaipur

Work Experience

Bhagwan Mahaveer Hospital & Research Center, Jaipur

Consultant in Medical Oncology

April 2021— Present
  • Working in a multi super-specialty hospital
  • Patient Counselling
  • Treatment planning
  • Treatment planning with MDT
  • Management of Oncology emergencies
  • Clinical research and trials of Biosimilars
  • Supportive care of admitted patients
  • Chemotherapy administration
  • Palliative Care
  • procedure : Bone marrow aspiration and biopsy and lumbar puncture
  • Teaching of Juniors residents and nurses
Apex Hospitals, Malviya Nagar Jaipur

Consultant Medical Oncology

August 2018 — April 2021
  • Running a department of Medical Oncology alone
  • Working in a multi super-specialty hospital
  • Managing patients in collaboration of other specialties and super-specialties
  • Baseline evaluation with diagnostic and staging workup
  • OPD, Day Care and IPD management
  • Managing Cross References
  • Patient Counselling
  • Treatment planning
  • Treatment planning with MDT
  • Management of Oncology emergencies
  • Clinical research and trials of Biosimilars
  • Supportive care of admitted patients
  • Chemotherapy administration
  • Palliative Care
  • procedure : Bone marrow aspiration and biopsy and lumbar puncture
  • Teaching of Juniors residents and nurses
Tata Memorial Hospital Mumbai

Senior Registrar in Medical Oncology

1st august 2014 — 31st July 2018
  • Studied basics and current standards of oncology
  • Baseline evaluation with diagnostic and staging workup
  • Patient Counselling
  • Treatment planning
  • Participated in tumor board meeting for treatment planning
  • Management of Oncology emergencies
  • Participated in Clinical research and trials
  • Worked with team of > 60 Medical oncologists
  • Supportive care of admitted patients
  • Chemotherapy administration
  • Palliative Care
  • procedure : Bone marrow aspiration and biopsy and lumbar puncture
  • Teaching of Juniors
Safdarjung Hospital, New Delhi

Senior Resident in Medical Oncology

31st july 2012 — 06th April 2014
  • Baseline evaluation with diagnostic and staging workup
  • Patient Counselling
  • Treatment planning
  • Supportive care of admitted patients
  • Chemotherapy administration
  • Palliative Care
  • procedure : Bone marrow aspiration and biopsy and lumbar puncture
  • Teaching of Junior residents and UG students

Qualifications

  • D.M. Medical Oncology - Tata Memorial Hospital, Mumbai, August 2014 to July 2017
  • M.D. General Medicine – S.N. Medical College , Agra, May 2009 to June 2012
  • M.B.B.S. - S.M.S.Medical College , Jaipur, Rajasthan 2001-2006

Education

DM Medical Oncology

Tata Memorial Hospital , Mumbai

August 2014 — July 2017
MD General Medicine

S N Medical College, Agra

June 2009 — May 2012
MBBS

SMS Medical College Jaipur
Internship from July 2006 to June 2007

september 2001 — July 2006

References

  • Dr. Sudeep Gupta – Professor medical oncology department, and Director, (CRC) ACTREC. sudeepgupta04@yahoo.com
  • Dr. Shripad D Banavali - Academic director (Dean) Of Tata Memorial Hospital Mumbai. banavali_2000@yahoo.com
  • Dr. NavinKhattry - Professor and BMT Program Coordinator, Department of MedicalOncology and Deputy Director, (CRC) ACTREC at Tata Memorial hospital. nkhattry@gmail.com
  • Dr Kumar Prabhash - Professor and Head Department of at Tata Memorial hospital. kprabhash1@gmail.com
  • Dr S.P. Katariya Head of Department of Medical Oncology, Safdarjung Hospital, New Delhi
  • Dr Sachin Jhawar -CEO Apex Hospitals Malviya Nagar Jaipur. dr.sachinjhawar@apexhospitals.com

Research Work

  • Letter to Editor : Management of Ovarian Cancer. CRST DOI 10.4103/CRST.CRST_128_19
  • Karpe A, Patil VM , Joshi A, Noronha V, Gupta S, Ramaswamy A , Sahu A , Doshi V , Gupta T, Rath S , Banavali S , Prabhash K . Weekly cisplatin (30-40 mg/m2) as radiosensitizer: Is it high or moderate emetic agent?: Indian J Cancer. 2016 Jul-Sep;53(3):454-456.
  • Patil VM, Noronha V, Joshi A, Ramaswamy A , Gupta S, Sahu A , DoshiV ,Gupta T, Rath S , Banavali S , PrabhashK .Adherence to and Implementation of ASCO Antiemetic Guidelines in Routine Practice in a Tertiary Cancer Center in India: JOncolPract. 2017 Jun;13(6):e574-e581
  • Trial ( awaiting for publication) - “ To study the Effect of structured teaching module on Capecitabine induced Hand –Foot syndrome in patients with Colorectal Cancer at Tertiary Care Centre.” A prospective randomized Control Trial.
  • VikasOstwal, Tarachand Gupta , Supriya Chopra , Sherly Lewis , Mahesh Goel, Shraddha Patkar , Nitin Shetty , AnantRamaswamy .Tolerance and adverse event profile with Sorafenib in Indian patients with advanced hepatocellular carcinoma: South Asian J Cancer 2017;6:144-6
  • AnantRamaswamy; RushabhKoathari; Ashwin Desouza; Tarachand Gupta; Sandeep Bairwa; Akhil Kapoor; Amit Kumar; Pradeep Ventrapati; MuktaRamadwar; SarikaMandavkar; Nita Chavan; AvanishSaklani; VIKAS OSTWAL. Adjuvant chemotherapy in stage II - III operated colon cancer patients from a non-trial cohort in a low colon cancer prevalence country and use of modified CAPOX. South Asian J Cancer
    Jul-Sep 2019;8(3):160-165.
    doi: 10.4103/sajc.sajc_176_18
  • Thesis in M.D. “ Evaluation of various ischaemic end points response in patient subjects for stress test and its correlation with various risk factors.”
  • Paper presentation on “ A study to compare the role of N-Acetyl Cysteine and combination of N-Acetyl Cysteine with Taurine in proteinuria in Diabetes mellitus” in UPDACON 2010 Jhansi
  • Poster presentation titled “Association of Lipoprotein (A) in Patients of Acute Myocardial Infarction” in IACM Patna 2011
  • Attended the ECG learning course, conducted by Indian Society of Electro cardiology on 6 th august 2011.

Achievements

  • 5 th rank in all India level entrance test of Tata Memorial Hospital for D.M. Medical oncology 2014
  • Only candidate selected in July 2014 for PhD in medical oncology at AIIMS
  • 771st Rank in all India entrance test for Medical post-graduation courses 2009
  • 30 th Rank in Rajasthan Pre Medical Test 2001
  • Gold medal in intracollege Carom championship in Mixed double category in 2004

Faculty in Conferences

  • Organizing secretory of 2 days National webinar on genitourinary cancers GU Conundrum 2020, 24th and 25th September.
  • Panelist in Session of Small Cell Lung Cancer in webinar of OncoWebex2020on 30th September 2020
  • Chairperson in Session " Screening and early lung cancer " in lung cancer master class 19th July 2020
  • Panelist in webinar of Breast Cancer Chakravyuh - Breaking Barriers In session on Her2 Neu MBC
  • Chairperson in webinar of Best clinical oncology symposium 10th June 2020
  • Panelist in “Update in Lung Cancer YER 2019”, Mumbai 20-22 December 2019
  • Panelist in IBCC 2019 Jaipur in session on Multimodality treatment of LABC
  • Moderator in Jaipur CME on lymphoma 19th July 2019 .
  • Speaker : Abstract of Phase III Trial of Rd Followed by R vs Continuous Rd in Intermediate-Fit Elderly
  • Patients With Newly Diagnosed Multiple Myeloma in Hematology update 2019" Jaipur. 05-01-2019
  • Panelist in “Update in Lung Cancer YER 2018”, Mumbai 15th and 16th December 2018
  • Chairperson in session 3of Lung Cancer in “UAE Cancer congress 2018” , Dubai 11th to 13th October 2018
  • Quiz Master and Panelist in “ IBCC 2018” Jaipur.

Ongoing Trials

  • Head And Neck : A Phase II Clinical Study to evaluate the efficacy and safety of NRC-2694-A in patients with Recurrent Head and Neck Squamous cell Carcinoma.
  • RCC-A Randomized, Open Label, Multi-Center, Two-Treatment, Two-Period, Two-Sequence, Two-Way Crossover, Multiple Dose, Steady-State Bioequivalence (BE) Study of Pazopanib HCL 200mg Tablets at a Dose of 800mg (4 * 200 mg tablets) of Lotus Pharmaceutical Co., Ltd., Taiwan with VOTRIENT® (Pazopanib HCL 200mg) Tablets at a Dose of 800 mg (4 * 200 mg tablets) of Novartis Pharmaceuticals Corporation, USA in Subjects with Advanced Renal Cell Carcinoma Under Fasting Condition
  • Ongoing Biosimilar Trial (Recruitment Completed) :Randomized, Assessor- Blind, Multicentre,Parellel Group, Two Arms, Clinical Study to Assess the Efficacy, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety of Rituximab ( Test Product, Zydus) in comparision with Rituximab( Reference product, Roche/Genentech) in Patients with Diffuse Large B Cell Lymphoma (DLBCL).
  • Ongoing Biosimilar Trial (Recruitment Completed) : A Prospective,Randomized, Multicenter Comparative, Open label ,Parellel Study to evaluate the Efficacy, Safety and Pharmacokinetics, of Test-Trastuzumab Emtansine ( ZRC3256;Cadila Healthcare Ltd) and Reference- Trastuzumab Emtansine(Kadcyla, Roche Products (India)Pvt.Ltd) in HER 2- Positive Metastatic Breast Cancer Patients

The Trusted Treatment

Cancer could be of many types and can be occur at many different body parts. We provide the following cancer treatments using different therapies. We build trust with our patient for faster recovery and best satisfaction of the patient.

Brain Tumor

Kidney Cancer

Bone Cancer

Esophageal Cancer

Gallbladder Cancer

Uterine Cancer

Ovarian Cancer

Our Oncologists Services

Along with providing the best consultation of cancer, our oncologist provides you the therapies depending upon your cancer. The therapies includes Chemotherapy, Immunotherapy, Hormonal Therapy and others.

Dr. Tarachand

M.D. D.M. Medical Oncology


Specializations

Specialist in Chemotherapy, Targeted Therapy and Immunotherapy

Contact Info

Mon-Sat

Bhagwan Mahaveer

Cancer Hospital &

Research Centre

 9 AM To 4 PM

Mon-Sat

Clinic

6 PM To 8 PM
Sunday Not working

A delay in the treatment always worsen the disease

Are you facing symptoms that can lead to cancer? Consult the oncologist Dr. Tara Chand to get immediate consultation and diagnosis.